David Ebersman

David Ebersman, Facebook IPO
David Ebersman, Facebook IPO

Ebersman joined Facebook in September 2009, taking over from ousted financial chief Gideon Yu. Prior to that, he served in various positions during his 15-year stint at biotech firm Genentech, including chief financial officer and executive vice president. He's also worked as a research analyst at Oppenheimer & Company.

As a prime mover in Facebook's IPO process, Ebersman has garnered praise for his low-key, measured approach. Although not as publicly familiar as Zuckerberg or Sandberg, Ebersman is well-regarded for his strategic leadership among those familiar with the company.

Born: 1969
Lives: South San Francisco, CA
Education: Brown University, B.A.

Relationship to Facebook

Described by the Wall Street Journal as "the Doogie Howser of CFOs" due to his relative youth as Genentech's financial chief. Ebersman holds about 2.4 million shares, and 7.4 restricted stock units, which will make him rich enough to be the Doogie Howser of Retirees if he chooses.

Career Profile

Current Occupation: Chief Financial Officer, Facebook
Former Occupation: Genentech, Oppenheimer & Company

Contact Business


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    Get these newsletters delivered to your inbox, and more info about our products and service. Privacy Policy.